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ABSTRACT 
 
COMPARISON OF NUTRITION OUTCOMES BY ENTERAL NUTRITION 
FEEDING METHOD DURING WEANING FROM PARENTERAL NUTRITION IN 
CHILDREN WITH INTESTINAL FAILURE 
by 
Elizabeth K. Thomas 
 
Objective: To evaluate the difference in time to achieve enteral autonomy, survival, and 
linear growth velocity by parenteral nutrition (PN) weaning strategy in children with 
intestinal failure. 
Methods: Analysis of retrospectively reviewed medical record data included comparison 
of time to PN wean since the date of the first clinic visit, survival time, and differences in 
height z-scores between PN wean and two-years post-wean by whether an enteral tube 
feeding (TF) was used during the weaning process. 
Results:  32 of 49 children (65%) received an enteral TF with or without oral diet during 
the two-year follow-up period.  Median time to weaning did not differ significantly 
between those who received a TF (21.5 months [IQR;10.3, 37.8]) vs. oral diet alone (19.0 
months [IQR; 14.5, 40.0]).  The probability of survival did not differ by TF status with 
only one death in the TF group.  Linear growth velocity between the time of PN weaning 
to two-years post-wean did not significantly differ by TF status. Children who weaned 
via oral diet alone had a similar decrease in height z-score vs. those who received a TF (-
0.14 vs. -0.15, respectively); however, a greater increase in z-score between years 1 and 2 
post-wean was observed (+0.27 vs. +0.11, respectively). 
Conclusions: No association between weaning strategy and outcomes in children with IF 
was observed.  Linear growth velocity declines during the first year after PN weaning but 
rebounds in year two.  Future studies should examine the long-term benefits of oral 
feeding vs. TF on intestinal adaptation.
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CHAPTER I 
 
COMPARISON OF NUTRITION OUTCOMES BY ENTERAL NUTRITION 
FEEDING METHOD DURING WEANING FROM PARENTERAL NUTRITION IN 
CHILDREN WITH INTESTINAL FAILURE 
 
Introduction 
Intestinal failure (IF) in the pediatric population is a clinical condition 
characterized by malabsorption, malnutrition, and growth retardation secondary to 
extensive loss of intestinal length or function.1  Short bowel syndrome (SBS) occurs after 
massive resection of the small bowel, often due to necrotizing enterocolitis, intestinal 
atresia, midgut volvulus, or gastroschisis.2 Resection is the most common cause of IF in 
children.2 Many infants with SBS are born prematurely and at very low birth weight 
(<1,500 grams); most receive parenteral nutrition (PN) beginning within the first three 
days of life.3  Children with IF caused by SBS undergo progressive intestinal adaptation 
of their remaining bowel over a period of a few months to years. During this time, 
medical and surgical management includes maintenance of fluid and electrolyte balance 
and enteral nutrition (EN) and PN support.4  Adaptation is defined as an enhanced 
absorptive capacity of residual small bowel through increases in cellular proliferation, 
villus height, and crypt depth. The most effective strategy for stimulating intestinal 
adaptation, achieving intestinal rehabilitation, and reducing the risk of PN-related 
complications remains the provision of EN.5 
Advances in neonatal intensive care, anesthesia, and surgical techniques have 
resulted in the survival of progressively smaller infants.3 The incidence of SBS is 
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currently estimated to be 3 to 5 per 100,000 births per year and the prevalence of SBS has 
likely increased in recent years due to advances in medical and nutritional care.3,6  
Approximations of the prevalence of IF and SBS are difficult to determine in children as 
they are based on the number of patients receiving home PN, currently ~16,000, which is 
the therapy most often indicated for SBS.3  Although cases of IF and SBS are rare, the 
human and societal costs are considerable with medical charges exceeding $500,000 in 
the first year of life and averaging ~$300,000 in subsequent years.7 Children with IF are 
at risk for multiple complications including metabolic abnormalities, mechanical and 
infectious complications of central venous catheters, structural and functional bowel 
disorders, chronic liver disease and a lower quality of life.3 Although the survival rate for 
pediatric patients with SBS has improved with the use of PN, many pediatric patients still 
fail to maintain adequate somatic growth, and the complications associated with its long-
term use may be life-threatening.8,9 Morbidity and mortality rates in patients with IF and 
SBS have been associated with many factors including: 1) age at the time of surgery, 2) 
residual bowel length, 3) function and adaptive capacity of the remnant bowel, 4) the 
ability to achieve enteral autonomy, 5) incidence of sepsis, and 6) the development of PN 
associated liver disease.3,5  
Maintenance of nutritional status and growth in children with SBS can be difficult 
because of the potential clinical manifestations of the disorder, including feeding 
intolerance, altered intestinal motility, malabsorption of electrolytes and macro- and 
micronutrients,10,11 and oral aversion.12  The survival rate for many children with SBS, 
the avoidance of long-term PN associated complications such as central line catheter 
infections, liver disease, and death remain a constant concern and challenge for 
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healthcare providers.13 The nutritional support of patients with SBS is complex and must 
be individualized based on the acute and chronic medical issues and conditions of each 
patient.9 After patients are stabilized postoperatively, standard practice has been to 
gradually cycle PN hours downward while concurrently maximizing enteral tube 
feedings.  Despite the use of PN and standard medical management, growth failure by 
anthropometry is still observed in a high percentage of patients.  Rates of underweight 
(weight for age <5th percentile) and stunting (length or height for age <5th percentile) 
have been reported between 21-38% and 34-46%, respectively in this population.3,9   
Interdisciplinary management of children with chronic intestinal disease is 
essential to improve the outcome of the disease process as it can result in cessation of PN 
support, accelerated growth, and improved survival.9,14 Moreover, interdisciplinary care 
serves to enhance communication of the treatment plan to the patient/family as well as 
maintain the continuity of care throughout the entire treatment process. The high 
mortality rate of patients in the IF and SBS populations, who have been neither weaned 
from PN nor transplanted, emphasizes the critical importance of a concentrated effort 
toward the goal of eliminating PN support.9 The initial publication of the Pediatric 
Intestinal Failure Consortium, which included 14 pediatric centers in the United States 
and Canada, reported that of 272 children examined retrospectively, breast milk was 
given to 52 (19%); twenty different infant formulas were used as the initial enteral diet 
and 40 different formulas were used overall.3 While practice variations are expected, the 
effectiveness of these strategies it is important to compare to determine a best practice.3 
The Intestinal Care and Rehabilitation Center (ICARE) at Children’s Hospital of 
Pittsburgh of the University of Pittsburgh Medical Center (UPMC) has served as a 
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leading referral center for the evaluation and management of children with IF or SBS 
since 1996. Previous research conducted in Pittsburgh found that patients weaned from 
PN achieved 93% survival vs. 26% for those not weaned.9 Children with SBS require 
months to years to adapt, and still others are never able to achieve enteral autonomy.3,14  
The confluence of factors such as diagnosis, intestinal anatomy, nutritional intake or 
growth status that contribute to the problem within this population is not yet understood.  
Nutrition management strategies vary between intestinal care centers and many practices 
are not evidence-based.3 Therefore, we proposed the first observational retrospective 
study to evaluate the effectiveness of a standard PN weaning regimen using enteral tube 
feedings vs. a more direct approach of weaning to oral diet in a sample of infants and 
children with SBS.  This research enables us to better understand factors that contribute 
to successful weaning from PN and develop a treatment approach to improve outcomes 
for these children. 
The ICARE registry, which existed between 1996 and 2009, contains the nation’s 
largest center database for children with IF/SBS (n=444). In 2010, the center clinicians 
adopted a regimen for patients with IF and SBS that involved weaning from PN directly 
to oral diet without the use of supplemental tube feedings.  This change in the nutrition 
management protocol has provided us with the opportunity to assess the effect of using 
tube feedings vs. oral diet during weaning of PN on survival, nutritional intake, growth, 
and time to enteral autonomy.  The benefits of using a regimen that does not incorporate 
supplemental tube feedings include: 1) reduced discomfort to children, 2) lower cost, 3) 
decreased stooling, 4) reduced risk of losing the suck/swallow reflex, and 5) less oral 
aversion.  Continuous enteral feeding has been suggested to ensure better absorption of 
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calories.  However, ultimately intestinal adaptation is what enables enteral autonomy and 
the discontinuation of PN.  Early parabiotic mouse studies clearly showed the hormonal 
influence on intestinal adaptation.15  We hypothesize that intermittent feeding provides an 
advantageous milieu for intestinal adaptation and that the introduction of oral feeding 
may outperform continuous tube feedings for this reason. By resuming the ICARE 
registry to include patients referred since 2009, we assessed this most recent change in 
practice and compared outcomes to those achieved using the previous standard of 
nutritional care.  
 
Specific Aim:  To describe and compare the effect of a PN weaning strategy with and 
without continuous enteral tube feedings on survival, nutrition intake, growth, and time to 
achieving enteral autonomy in children with IF. 
Hypothesis 1: The time to achieve enteral autonomy will be shorter in patients 
who did not receive a continuous enteral tube feeding during the weaning process. 
Null Hypothesis 1: The time to achieve enteral autonomy will not differ by PN 
weaning approach. 
  
Hypothesis 2: Survival time will be longer in patients who did not receive a 
continuous enteral tube feeding during the weaning process. 
Null Hypothesis 2: Survival time will not differ by PN weaning approach. 
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Hypothesis 3: Linear growth velocity will be greater in patients who did not  
receive a continuous enteral tube feeding during the weaning process. 
Null Hypothesis 3: Growth will not differ by PN weaning approach.  
 
  We anticipated identifying a high percentage of children who remain on PN 
beyond the first year after initial surgery. We hypothesized that participants who were 
weaned from PN using a more direct approach to oral diet (without continuous enteral 
tube feeding) will have a shorter time to weaning than those who received enteral tube 
feedings during the transition process.  The purpose of this study is to describe the 
medical, nutritional, and growth outcomes of children with SBS as they transition from 
PN to oral nutrition and to evaluate the effectiveness of various nutrition strategies on 
outcomes, including survival, nutrition intake, growth, and time to achieve enteral 
autonomy.  Our future goal is to conduct a multicenter prospective study to assess 
nutritional interventions in children with intestinal failure that will shorten time on PN 
and reduce the morbidity and mortality associated with its use.  
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CHAPTER II 
 
Review of Literature 
 
Pediatric Short Bowel Syndrome 
 Short Bowel Syndrome is traditionally defined as a clinical condition resulting 
from extensive resection of the small bowel, congenital defect, or disease-associated loss 
of absorption that is characterized by inadequate absorption of enteral nutrients.2,5,16,17 
Most commonly, SBS occurs following significant injury to the gastrointestinal tract or 
intestinal failure, which is the reduction in functional intestinal capacity to maintain 
growth, hydration, and/or electrolyte balance requiring dependence on PN for greater 
than 4 weeks. 2,5,18 While SBS can be congenital or acquired, in pediatric patients, 
particularly infants, necrotizing enterocolitis (NEC) and subsequent surgical intervention 
is the most common cause, with 22% to 50% of SBS cases resulting from NEC.2,5,19,20 
Additional causes of SBS include intestinal atresia, abdominal wall defects, volvulus, 
Hirschsprung disease, and meconium ileus.20,21 Though the etiology and pathophysiology 
of necrotizing enterocolitis are not fully understood, NEC is characterized by ischemia, 
severe damage or necrosis of intestinal cells, and ulcerative inflammation of the intestinal 
wall.19,22 While NEC may be treated with conservative, symptomatic treatment, such as 
fasting, PN, fluid balance, and pain medication, bowel resection is often necessitated, 
leading to SBS.22 
Full-term infants typically have between 200 and 250 cm of small bowel at birth, 
while those with SBS have a portion of small bowel that is nonfunctional or removed.2,19 
The resulting anatomy of the gastrointestinal tract typically falls into one of three 
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categories: jejuno-colic anastomosis, end-jejunostomy, or jejuno-ileal anastomosis. The 
pathophysiology of SBS varies widely depending on the amount and portion of intestine 
resected. 2,19,23 Jejuno-colic anastomosis results from removal of the ileum and often 
ileocecal valve leaving the remaining jejunum and colon.24 Patients with removal of the 
ileum, colon, and some portion of the jejunum have an end-jejunostomy, and those with a 
primarily jejunal resection with more than 10 cm of ileum and colon remaining have a 
jejuno-ileal anastomosis.24 Because the portion and length of remaining bowel is 
indicative of absorption, hormone and enzyme production and secretion, and adaptive 
capacity, the length of small bowel remnant remaining is one of the essential variables 
predicting survival and weaning of PN.2,23 The potential problems associated with 
resection of various portions of the small intestine are shown in Appendix A 
 Treatment of SBS is focused on maintenance of normal growth and development 
and restoration of full EN, and prognosis is closely related to 1) age at the time of 
surgery, 2), site and amount of bowel resected, 3) function (absorption and motility of the 
remnant bowel), (4) adaptive capacity of the remnant bowel, 5) injury to the bowel (due 
to infections, bacterial overgrowth, ischemia, stricture), and 6) whether complications 
(liver disease, recurrent line infections, and loss of vascular access) associated with 
chronic PN occur.5,19,21  
 
Intestinal Adaptation 
 Following intestinal resection, there is decreased mucosal surface area and 
decreased intestinal transit time, which results in reduced intestinal absorption of 
nutrients.19,25 Intestinal adaptation is an innate response that includes both anatomic and 
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physiologic changes of the intestine whereby the bowel attempts to regain absorptive 
capacity and transit time comparable to the level prior to resection. 2,19,23,26 Adaptation 
begins immediately following the resection and continues for at least two years, 
sometimes extending to more than three years.2,19,23,26 While the physiologic changes are 
poorly understood, intestinal adaptation is known to be affected by EN, circulating gut 
hormones, and endogenous luminal secretions.19 Beginning EN as early as is medically 
feasible is integral to intestinal adaptation.19 Furthermore, circulating enteroglucagon and 
luminal cholecystokinin and secretin stimulate intestinal cell proliferation, and these 
luminal secretions are stimulated by enteral nutrition.19 
While the degree of adaptation depends on the site and length of the remaining 
bowel, some degree of adaptation can occur no matter the remaining length of bowel 
remaining.19,23 When comparing resection of various portions of the small intestine, 
absorptive and adaptive capacity of each section of the intestine must be considered. The 
ileum is responsible for fluid and electrolyte management, absorption of a multitude of 
nutrients, including vitamin B12, A, D, E, and K, phosphorus, and zinc, and has a greater 
capacity for adaptation both structurally and functionally, so resection of portions of the 
duodenum or jejunum are better tolerated in terms of nutrient and electrolyte maintenance 
than ileum resection.2,23 Overall, intestinal adaptation results in increased small bowel 
surface area, villus length, intestinal crypts, and length and diameter of the remaining 
intestine that ultimately leads to increased surface area for digestion and absorption.19  
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Treatment Strategies 
Pharmacologic Intervention 
 Many clinical manifestations of SBS can be treated with pharmacologic 
interventions.19 Gastric hypersecretion is a common result of intestinal resection and 
further inhibits absorption because the increased acidity inactivates pancreatic enzymes 
and precipitates bile acid while also damaging the intestinal epithelium.5,19  Therefore, 
gastric hypersecretion should be managed quickly with an H2 receptor antagonist or 
proton-pump inhibitor.5,19 Intestinal transit time is reduced in SBS resulting in decreased 
nutrient absorption and often excess stool.19 Pharmacologic intervention can be used to 
slow transit time, optimize absorption, and encourage weaning from parenteral nutrition 
more quickly.19  
Small bowel bacterial overgrowth (SBBO), a common problem in SBS, occurs 
when excess bacteria exists in the small intestine.19,27 While some patients may tolerate 
SBBO and benefit from the production of the production of short chain fatty acids, others 
may experience feeding intolerance, abdominal distention, gassiness, diarrhea or 
increased ostomy output, or early satiety and may have further reduced nutrient 
absorption.5,19,20  Furthermore, SBBO is associated with villous atrophy and mucosal 
inflammatory response, and the risk for developing a bloodstream infection is higher in 
patients with SBS and SBBO than those without SBBO.28   Pharmacologic intervention is 
necessary to reduce bacterial overgrowth and promote mucosal health and feeding 
tolerance, but large randomized control trials evaluating antimicrobial treatment are 
lacking.5,19,29  Diagnosing SBBO is challenging because the associated symptoms are 
often indistinguishable from IF, an endoscopy procedure to obtain luminal samples is 
 
 
 
 
11 
invasive, and breath hydrogen tests may be unreliable in SBS patients.20  Therefore, SBS 
patients with symptomatic SBBO or an anatomic predisposition to SBBO are treated with 
cycled antimicrobials.20,29  Antimicrobials are given for a one to two week cycle each 
month, and a different antimicrobial is prescribed at each monthly administration to avoid 
bacterial resistance.20,29  Pharmacologic interventions for the management of SBBO 
symptoms include stool bulking agents used to limit bacterial translocation, glutamine 
supplementation to increase intestinal immunity, and probiotics; however, data detailing 
the risks and benefits of glutamine and probiotic supplementation are limited.29 
 
Surgical Management 
 Surgical intervention may be indicated to promote intestinal adaptation and 
enteral autonomy. 19,26 These interventions include procedures to increase intestinal 
surface area for absorption, improve motility through the small intestine, and slow 
intestinal transit time. 19,26 Surgical interventions may also be used to lengthen the 
intestine through serial tapering enteroplasty (STEP) or Bianchi procedures.19,26 If other 
medical or surgical interventions are unsuccessful or additional complications arise, 
isolated intestinal transplantation is a possiblity.26 Additionally, for patients who have 
developed end-stage liver disease related to long-term PN therapy, intestine-liver 
transplantation may be considered.24 While surgical intervention may be necessary, to 
promote intestinal adaptation, it should be withheld for at least one year following small 
bowel resection.19  
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Nutrition Therapy 
Appropriate nutrition therapy for pediatric short bowel syndrome is integral for 
promoting intestinal adaptation, managing fluid and electrolytes, reducing infection and 
disease associated with intestinal resection and PN, and improving overall health 
outcomes. Nutrition management includes recommendations for macronutrient 
composition of PN and EN as well as micronutrient, hormonal, and trophic 
supplementation. 
Intestinal failure-associated liver disease is common in patients with SBS relying 
on PN, and intravenous (IV) lipids are closely associated with its development.5 The 
American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) recommends lipid 
dosage in the PN solutions be between 0.5 g/kg/day and 1 g/kg/day to reduce the risk for 
essential fatty acid deficiency while also reducing the risk for Intestinal Failure 
Associated Liver Disease (IFALD).5 Though closely managing lipid content of PN is 
necessary to prevent complications, the inevitable calorie deficit is most often replaced 
with dextrose.5 A.S.P.E.N., the European Society for Pediatric Gastroenterology 
Hepatology and Nutrition (ESPGHAN), and the American Academy of Pediatrics 
recommend limiting the glucose infusion (GIR) rate to 12-14 mg/kg/min to prevent 
hepatic steatosis.5 If meeting energy needs at this GIR is impossible, increases in PN 
glucose content should be made with close monitoring for hyperglycemia and liver 
disease.5 
When beginning trophic EN feeding in patients with short bowel syndrome, 
continuous EN is arguably most appropriate to promote better tolerance, improved 
absorption, and continuous saturation of carrier proteins in the intestinal lumen.5,20,21,23,30  
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Human milk or an amino acid-based formula is the optimal choice for enteral 
feeding and may reduce the duration of PN.5,21,23 At initiation of EN, human milk should 
be provided for all infants when available because it contains growth factors, 
immunoglobins, long-chain fatty acids, and free amino acids that promote intestinal 
adaptation. 20,30  Protein concentration and caloric density of breast milk is limited, so 
hydrolyzed protein may be added after considering growth parameters and blood urea 
nitrogen levels.20   
When breast milk is not available, in older children, or with a protein allergy, an 
elemental amino-acid based formula is appropriate.20  Amino-acid based formulas 
contain long-chain and medium-chain triglycerides that promote intestinal adaptation and 
ensure direct absorption by enterocytes.5,21,23,30 Macronutrient composition should 
include a 30%:70% ratio of medium-chain triglycerides to long-chain triglycerides to 
promote fat absorption.5 It is recommended that EN begin at a concentration of 20 
kcal/30 mL and be increased by 0.5 to 1 mL/kg/day to reduce the risk of volume-related 
complications.23  
Because micronutrient absorption will differ depending on the type of bowel 
resected and may be hindered by a variety of medical complications associated with SBS, 
nutrient supplementation must be monitored closely and supplemented as necessary, 
particularly when PN is discontinued.19,21  To differing degrees, patients with SBS will 
likely have decreased fat-soluble vitamin absorption due to bile acid deficiency; 
therefore, vitamins A, D, E, and K require supplementation in water-soluble form.21  
Depending on the remnant bowel and degree of adaptation, phosphorus, magnesium,  
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selenium, copper, iron, calcium, zinc, and vitamin B12 may also necessitate 
supplementation (Appendix A).19,21,24,31 
 Growth hormone (GH) has been shown to promote mucosal cell proliferation, 
increase mucosal height, and increase water, sodium, and amino acid absorption in 
patients with SBS.5,32 Unfortunately, data supporting the benefits of GH on improving 
tolerance of EN and increasing body weight, lean body mass, and fat-free mass in 
pediatric patients are inconclusive; therefore, GH is not approved for use in the pediatric 
population.5 
 Glutamine (Gln), a nonessential amino acid that is utilized as a major fuel for 
intestinal mucosal cells and immune cells, is found abundantly in human milk; however, 
Gln is not included in standard IV amino acid solutions. While Gln is adequately 
produced during times of health, supplementation during catabolic conditions may be 
necessary.33 Multiple studies suggest Gln supplementation enhances gut mucosal growth, 
repair, and function, increases duodenal villus height, reduces intestinal mucosa atrophy, 
improves nitrogen balance, and decreases gut-origin sepsis.5,33 Despite these known 
benefits of supplemental Gln, a multicenter clinical trial of extremely low birth weight 
infants found that PN supplemented with Gln did not decrease mortality, increase 
tolerance of enteral feeds, effect growth, or reduce incidence of late-onset sepsis.34 
Supplemental Gln is currently not approved for pediatric use; though, additional studies 
are ongoing.5 
 Glucagon-like peptide 2 (GLP-2) is a trophic peptide produced by mucosal cells 
in the ileum and proximal colon and pancreatic cells that has been shown to stimulate 
crypt cell proliferation and increase villus growth in the jejunum and ileum.5,33,35 GLP-2 
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is often diminished in patients with small bowel resection, but its use is not approved for 
pediatric patients since there are no pediatric studies examining the safety and efficacy of 
GLP-2 supplementation.5 
 Soluble fiber slows gastric emptying and intestinal transit, which are necessary to 
increase absorption in patients with SBS.5 Additionally, soluble fiber is metabolized by 
colonic bacteria to produce short-chain fatty acids, which can be used as an energy source 
for colonocytes and promote sodium and water absorption.5 Several studies indicate a 
potential role of supplemental soluble fiber in improving diarrhea associated with 
SBS.5,21,36 
 
Pediatric Nutrition Assessment 
 As defined by the Academy of Nutrition and Dietetics, a nutrition assessment is 
the process “to obtain, verify, and interpret data needed to identify nutrition related 
problems, their causes, and significance.”37,38 Because of the intensive growth and 
development occurring through infancy and childhood, pediatric patients are particularly 
vulnerable to nutrition-related concerns and malnutrition.38 A comprehensive nutrition 
assessment is imperative for pediatric patients, especially those with nutrition-related 
chronic conditions like SBS.38 Nutrition assessment is comprised of five categories: 
food/nutrition-related history; anthropometric measurements; biochemical data; medical 
tests and procedures; nutrition-focused physical findings; and patient history. Data can be 
obtained from the medical record, through patient and caregiver interviews, and in the 
nutrition-focused physical assessment.38 Often, extensive information can be gleaned 
from the patient’s medical record, particularly if the patient’s medical history includes 
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past visits to specialty clinics or other providers.38 In the record, the following should be 
noted: reason for clinic visit or referral; medical history, surgeries, and nutrition-related 
conditions; current medications, supplements; laboratory data, medical tests, and 
procedures; Tanner stage; growth history; anthropometric measurements with growth 
chart plots and z scores; and prenatal and birth history.38 
 
Anthropometric Measures 
 Anthropometric measures are essential for observing growth changes over a 
continuum of time and should be assessed at admission, throughout hospital stay, and 
prior to discharge.38 Often, correct anthropometric measures are difficult to obtain due to 
contractures, poor cooperation, or clinician error.38 This increases the importance of 
routine anthropometric measures.  
 
Length and Height 
Traditionally, for children < 24 months old, length should be recorded using a 
solid length board or infantometer with two clinicians present, one to hold the head of the 
patient while the other places the patient’s feet at a right angle with legs straight against 
the lower plate.38 Length is recorded to the nearest 0.1 cm, and the process should be 
repeated to ensure accuracy.38 For patients > 2 years old, height should be measured 
using a fixed stadiometer or vertical measuring tape secured to a solid surface.38 The 
patient should stand looking straight ahead with heels together and heels, buttocks, 
shoulders, and head resting against the solid surface where the measuring tool is 
located.38 Height is recorded to the nearest 0.1 cm, and the process should be repeated to 
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ensure accuracy.38 In patients with limitations hindering the ability to use a standard 
measuring method, alternative methods, such as knee height measure, arm span, and 
tibial length, should be used. 
 
Weight 
 Weight is a necessary parameter when assessing growth and nutrition; however, 
weight can fluctuate widely depending on time of day, intake, IVs, and scale used, among 
other factors, so weight should be recorded at all clinician interactions. 38 In infants, 
weight should be measured naked or with a dry diaper using a pan scale.38 Pan scale 
weight is recorded to the nearest 10 g.38 Weight for children greater than two years of age 
should be measured using a platform scale with minimal excess weight from clothing and 
shoes. Platform scale weight is recorded in kilograms to the nearest one decimal place.38 
If a weight is unable to be obtained by traditional methods, a bed scale, wheelchair scale, 
or hold and subtract method may be used.38 
 
Mid-Upper Arm Circumference and Triceps Skinfold 
When there is concern that weight measures may be inaccurate or fluctuating due 
to fluid changes, Mid-Upper Arm Circumference (MUAC) and Triceps Skinfold (TSF) 
are easily obtainable measures that can be used as predictors of malnutrition risk and 
mortality.38 These measures are often better at predicting body composition and 
malnutrition because unlike weight and BMI, they are more indicative of muscle and fat 
mass.38  
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Weight for Length 
For patients less than two years of age, weight for length is a comparison used to 
assess proportionality and linearity of growth using the World Health Organization 0-to 
24-month growth charts.38 Weight for length and growth chart plots can be used to assess 
linearity of growth over time. 
 
Body Mass Index 
Proportionality and acceptability of weight and height for patients older than two 
years is assessed using body mass index.38 
BMI = Weight in kg/Height in m2 
BMI can be used to assess trends over time and visualize growth patterns. 
However, BMI may be skewed in individuals who have increased muscle mass or short 
stature, so additional measures like MUAC and TSF should be gathered during the 
assessment to determine if BMI is an adequate measure of growth.38  
 
Growth Charts 
Growth charts provide necessary data for determining pediatric nutrition status. 
Pediatric growth rate varies widely through the growth process, so differing growth are 
used depending on the age of the patient. For term infants up to two years of age, the 
2006 WHO charts are most appropriate because they were developed using data from 
exclusively breastfed children from diverse backgrounds and geographic regions. Growth 
charts from the WHO can be used to determine percentiles, and z scores are available for 
boys and girls for weight for age, length for age, head circumference for age, and weight 
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for length.38 At two to twenty years of age, patients are plotted on the Centers for Disease 
Control and Prevention (CDC) growth charts published in 2000.38 CDC growth charts are 
available for boys and girls for weight for age, stature for age, and BMI for age.38 For 
patients born prematurely or those with Down syndrome, Turner syndrome, Cerebral 
palsy, Prader-Willi syndrome, Achondroplasia, Noonan syndrome, or Williams 
syndrome, specialty growth charts exist that correspond with various growth differences 
in these populations.38 
 
Nutrition-Focused Physical Exam 
 The nutrition-focused physical exam (NFPE) is a system-based examination of 
each region of the body to evaluate nutrition status.39 The exam focuses on 
anthropometric measurements, visualization, assessment of subcutaneous fat and muscle 
stores, and assessment of the hair, eyes, oral cavity, skin, and nails for micronutrient 
deficiencies.38 The NFPE is completed using inspection and palpitation, though 
percussion and auscultation may be included if deemed necessary.38 
 In infants and toddlers, fat stores should be assessed by palpating the orbital, 
buccal, triceps, ribs, and buttocks.38 As fat stores are depleted, bony prominences become 
more protuberant, depressions between bones are more apparent, and less fat is found 
pinching and rolling skin together.38  Muscle store assessment includes the temples, 
muscles surrounding the clavicle, shoulders, muscles overlying the scapula, quadriceps, 
and calves, and loss of muscle stores results in more apparent bony prominences and less 
resistance when muscular regions palpated..38 Micronutrient assessment is completed by  
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visually observing the eyes and oral cavity and by visually observing the hair and nails 
and palpating the skin (Appendix A).38 
 
Malnutrition 
Pediatric malnutrition is defined by A.S.P.E.N. as an imbalance between nutrient 
requirement and intake, resulting in cumulative deficits of energy, protein or 
micronutrients that negatively affect growth, development, and other relevant outcomes.40 
In patients with chronic conditions or who require long-term nutrition support, nutrition-
related issues are a concern, and patients with intestinal failure are at a higher risk for 
malnutrition.38,41 In the United States, most malnutrition results directly from acute or 
chronic illness, and in critically ill patients, malnutrition is associated with longer periods 
of ventilation, higher-risk of hospital-acquired infection, longer pediatric intensive care 
unit (PICU) and hospital stay, and increased mortality.38,42 Because of the adverse 
outcomes associated with malnutrition in critically ill patients, it is recommended that 
patients in the PICU undergo a thorough nutrition assessment within 48 hours of 
admission and weekly throughout hospitalization.42 While a standardized method for 
diagnosing pediatric malnutrition has not been established, several indicators have been 
identified for assessment and diagnosis. These include food and nutrient intake, 
assessment of energy and protein needs, growth parameters, weight gain velocity, mid-
upper arm circumference, and handgrip strength.40 When determining a pediatric 
malnutrition diagnosis, a nutrition assessment with data from five domains: 1) etiology 
and pathogenesis, 2) chronicity, 3) anthropometric measurements, 4) growth, and 5)  
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developmental and functional outcomes, should be collected to ensure accuracy and 
completeness.38 
Attention should be paid to those patients considered at-risk by A.S.P.E.N. 
criteria. Nutritionally-at-risk neonates who are at high nutrition risk are those born at less 
than 28 weeks gestational age, of extremely low birth weight less than 1000 g, 
establishing feeds after an episode of necrotizing enterocolitis or gastrointestinal 
perforation, or with severe congenital malformations like gastroschisis.43 Infants at 
moderate risk are those born preterm between 28 and 31 weeks, at a weight less than the 
9th percentile, at a very low birth weight of 1000-1500 g, or with an illness or congenital 
anomaly that compromises feeding.43 Children considered nutritionally-at-risk are those 
with a weight for length or weight for height or sex less than the 10th percentile or greater 
than the 95th percentile, body mass index for age or sex less than the 5th percentile or 
greater than the 85th percentile, increased metabolic requirements, impaired ability to 
ingest or tolerate oral feedings, documented inadequate provision of or tolerance of 
nutrients, or inadequate weight gain or a significant decrease in usual growth 
percentile.40,41 
 
Etiology and Pathogenesis 
 Malnutrition can be classified as illness or non-illness-related and can be further 
specified as acute or chronic.38 Illness-related malnutrition is related to one or more 
disease, illness, or trauma and results in nutrient imbalance from decreased intake, 
increased needs, increased losses, and/or altered utilization of nutrients.38 Non-illness-
related malnutrition is linked to environmental or behavioral factors that result in 
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decreased nutrient intake and can be associated with adverse developmental and/or 
physiologic outcomes.38 Malnutrition that has been present for less than three months is 
considered acute malnutrition and is most commonly seen using the measures of 
weight/age, weight/length, or BMI.38 Malnutrition that has endured for more than 3 
months is considered chronic malnutrition and is often seen in a skewed linear growth 
pattern or stunted growth.38  
 
Anthropometric Measurements 
 Anthropometric measurements are necessary for a malnutrition diagnosis and 
therefore should be recorded regularly and accurately.38 Measures like weight, 
length/height, and mid-upper arm circumference should be plotted on growth charts to 
determine growth.38 Z scores for body mass index for age (weight for length, < 2 years) 
or weight for age should be used to further assess patients who may fall on extreme ends 
of the spectrum, and head circumference for patients < 36 months of age should be 
documented.42 
 
Growth 
When anthropometric measures are plotted on a growth chart, the corresponding z 
score is used to determine the degree of malnutrition.38 A diagnosis can be further 
supported using multiple data points over time.38  The criteria for malnutrition diagnosis 
based on anthropometric measures appear in Appendix B. 
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Developmental and Functional Outcomes 
While handgrip strength can be used to assess functional status of patients greater 
than six years old with minimal physical or developmental limitations, often 
developmental and functional status is assessed through observation, care with the 
medical team, and/or a caregiver interview.38 A pediatric patient with malnutrition may 
have decreased mobility, muscle loss, or weakness, which may result in vent dependence, 
immune dysfunction, cognitive and developmental delays, or delayed wound healing.38 
 
Pediatric Nutrition Requirements 
Pediatric Critically Ill Patient 
 When determining a pediatric patient’s energy expenditure, indirect calorimetry is 
the most precise method because it accounts for the metabolic alterations that may occur 
throughout the course of an illness.40,42 Moreover, indirect calorimetry is independent of 
nutrition status, diagnosis, or severity of the illness.42 When indirect calorimetry is 
unavailable, predictive equations for energy and protein may be used. Evaluation of 
energy and protein needs regularly is important to adjust for changing needs throughout 
the course of illness and to ensure adequacy of energy intake.42 Despite evidence that 
most predictive equations are inaccurate, according to A.S.P.E.N., if indirect calorimetry 
is unavailable, the Schofield or Food Agriculture Organization of the United 
Nations/WHO equations are suggested for use without inclusion of a stress factor.42 Upon 
determining energy requirements, it is necessary to ensure that patients receive at least 
two-thirds of energy requirements by the end of the first week in the PICU.42 
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Adequate protein intake attenuates the loss of lean muscle mass and is necessary to 
achieve positive or neutral nitrogen balance. The Recommended Dietary Allowance and 
WHO recommendations should not be used to determine protein needs in critically ill 
patients because they were developed for use in healthy children.42 A minimum 
recommendation has been made by A.S.P.E.N. at 1.5 g/kg/day, but optimal protein intake 
may be higher, particularly in young children, critically ill patients, and patients receiving 
mechanical ventilation.42 While clinical expertise should be considered, the safety of 
protein intake of greater than 3 g/kg/day in children older than one month of age has not 
been established, so particular care and monitoring should be in place when protein needs 
are expected to be >3 g/kg/day.42  Recommended predictive equations for the pediatric 
critically ill patient appear in Appendix C. 
 
Premature Infant 
 Infants born prematurely have increased nutrient requirements compared to 
infants born at term, and adequate nutrient provision is necessary to promote growth 
similar to that of the in utero growth of a normal fetus.44 According to ESPGHAN 
guidelines, enteral energy requirements for neonates are 110-135 kcal/kg, and protein 
requirements are 3.5-4.0 g/kg.45,46 Because enteral nutrition promotes dietary induced 
thermogenesis, enteral needs are 10% higher than parenteral needs.45 Parenteral energy 
requirements are 110-120 kcal/kg, and protein requirements are 1.5-4.0 g/kg (Appendix 
C).31,45 
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Pediatric Nutrition Support 
Parenteral Nutrition 
Parenteral nutrition has dramatically changed the course of treatment for pediatric 
SBS and is an imperative piece of medical management.19,47 Patients with short bowel 
syndrome require supplemental PN to ensure sufficient growth and development.47 
Following intestinal resection, three distinct phases of intestinal adaptation and 
nutritional needs are noted. The phase immediately following intestinal resection is 
characterized by watery diarrhea, high gastric output, and significant fluid and electrolyte 
loss.2,5 While in this phase, PN is imperative for fluid and electrolyte management and 
maintenance of growth and development.5,19 Initially, fluid replacement is based on the 
amount lost from ostomies, fistulas, or drainage tubes and is replaced at 1 mL for every 
mL of fluid lost.5 The second phase of SBS is known as the transition phase and 
nutritional support becomes the primary focus, particularly introduction of EN.2,19 This 
phase generally occurs over one year or longer and is characterized by intestinal 
adaptation and mucosal hyperplasia.2,19 During the transitional phase, continuous enteral 
feedings should begin at a low rate.19 As tolerance increases and adaptation occurs, 
enteral feedings can be advanced while PN is reduced.19 The third and final phase 
following intestinal resection includes weaning of PN and complete enteral autonomy, 
and few adaptive changes or improvement are seen in phase three.2,19 
Though necessary for survival and growth, the duration of PN is associated with 
increased morbidity and risk for serious complications like sepsis and cholestasis.47 
Moreover, throughout the course of PN, complications like exhausted venous access 
routes, infectious complications, PNALD, and IFALD may arise. Historically, liver 
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failure has been responsible for 67% to 89% of deaths among PN-dependent patients with 
SBS.23,47 For these reasons, patients requiring PN should be monitored closely and 
advanced to enteral nutrition as quickly as medically feasible.5,9,47 
 
Enteral Nutrition 
When oral intake is not feasible, enteral nutrition is the preferred method for 
feeding in critically ill patients.42 However, for patients with short bowel syndrome, 
enteral feeding is not practicable at initiation of nutrition support.47 Following intestinal 
resection, structural and functional intestinal adaptation of the remnant bowel occurs 
leading to improved nutrient and fluid absorption.48 This includes bowel lengthening and 
thickening, increases in villus height and crypt depth, increased nutrient transporter 
expression, accelerated crypt cell differentiation, and slowed transit time.48 While 
intestinal length and quality of remnant bowel are integral in influencing the time at 
which EN can be initiated, early achievement of EN fosters intestinal adaptation and 
rehabilitation and should be strongly pursued as clinical circumstances allow.5 Regardless 
of remnant bowel length, enteral autonomy is achievable for most patients. 5,47 
While advancing EN, special attention should be paid to stool output, vomiting, 
and irritability to determine if advancement is appropriate.5  Stool output >40 mL/kg is a 
contraindication to increasing enteral feeds and suggests that fluid and electrolyte 
replacements are necessary.23,42  If stool output is between 30 and 40 mL/kg body weight, 
EN should be advanced cautiously.42  If feeding intolerance is suspected, it is 
recommended that feeds be reduced rather than stopped, unless there is evidence of 
underlying systemic illness or sepsis.20  A stepwise algorithmic method with the 
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assistance of a multidisciplinary nutrition support team is appropriate for use to advance 
EN.42 As EN is advanced and reaches >20% of nutrition intake, PN volume and duration 
should be reduced isocalorically.5  It is necessary to ensure sufficient calories are 
absorbed, so malabsorption should be evaluated and considered when increasing calories 
provided by EN.23 
As EN is advanced and tolerated, bolus oral feedings, at a volume of what is 
being tolerated continuously or less, should be introduced three to four times a day to 
promote oral-motor development and mimic normal infant eating patterns.5,21,30 Patients 
may have oral aversion due to delayed oral feeds, intubation, and cardiovascular 
instability; feeding therapy may be necessary to encourage oral intake.5 
 
Medical and Nutritional Outcomes 
Survival 
 Morbidity and mortality are high in infants and children with SBS.16 
Comprehensive, longitudinal, multidisciplinary care has resulted in improved outcomes 
in many cases, but21 despite improvements in care, mortality rates still consistently range 
between 20-30%.7 A 1972 study found survival rates for pediatric IF to be 54%.49 
Whereas, more recent studies have found survival rates to have improved to 70-
100%.3,14,50 A large retrospective cohort study found cholestasis and age-adjusted small 
bowel length to be significant predictors of mortality in pediatric SBS, and the SBS case 
fatality rate was 37.5%.16 In this study, gestational age, number of septic episodes, and 
etiology of SBS were not significant predictors of mortality.16 Additional studies have 
found hepatobiliary disease, episodes of sepsis, length of remaining small bowel, and loss 
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of the ileocecal valve to be significant contributors to increased incidence of morbidity 
and mortality among patients with SBS.9 While survival rates have increased and 
mortality and PN-associated morbidity have decreased, it appears that reducing the time 
to enteral autonomy will further improve survival.9 
 
Nutrition Intake 
 Following resection, most intestinal rehabilitation centers initiate continuous 
rather than bolus feeds because they are believed to be tolerated better, promote intestinal 
adaptation, and result in increased body weight and enteral retention of formula and 
nutrients.30,51 Few studies exist comparing nutritional value and absorption of EN with 
oral intake.23 A randomized crossover study of adults with SBS evaluated nutrient 
absorption by mode of nutrition therapy and found significantly greater absorption of 
carbohydrates, protein, and lipids with a tube feeding alone or a tube feeding alongside 
oral feeding than with oral feeding alone.17  
 Depending on the type of bowel resected, various micronutrient deficiencies may 
present. Deficiencies appear to be more prevalent after transition from PN to EN, but the 
risk for deficiency still exists with PN use.21 A longitudinal study of 30 children with IF 
found that patients receiving partial PN had a high prevalence of micronutrient 
deficiencies, including copper (56%), iron (46%), selenium (35%), and zinc (31%).52 
Another study found that after achieving enteral autonomy, vitamin D deficiency 
increased from 20% to 68%, and zinc deficiency increased from 31% to 67%.52 
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Growth 
 Meeting nutrition requirements and ensuring optimal growth can be challenging 
in pediatric patients with SBS because of fluid loss, nutrient malabsorption, electrolyte 
malabsorption, and PN-associated complications.10,11,13,16  Growth and development 
should be evaluated routinely to promote positive health outcomes. A study of pediatric 
patients on long-term PN found that 75% exhibited failure to thrive, often related to 
inadequate protein supplementation.53 In a study of very low birth weight preterm infants, 
those with short bowel syndrome were more likely to have growth delay with shorter 
lengths and smaller head circumferences than those without SBS, and between 18 and 22 
months, 74% were below the 10th percentile on at least one growth parameter (weight, 
length, or head circumference).54 After the onset of SBS, one study found that at six 
months, 76.5% of patients were classified as failure to thrive.16 At one year, patients 
exhibiting failure to thrive diminished to 68.3% and 47.6% at two and one-half years or 
later.16 The increased incidence of failure to thrive (body weight <5%) is indicative of the 
challenges of ensuring needs are met.16 
  
Achievement of Enteral Autonomy 
 Though PN is necessary to sustain growth and development in patients with SBS, 
promoting enteral autonomy by reducing the duration of PN may decrease complications 
and improve survival for pediatric patients with SBS while also promoting intestinal 
adaptation and maintenance of structural and functional integrity of the remaining 
bowel.20,21,23 Many studies have found intestinal length to be the primary predictor of 
enteral autonomy.16,55,56 Other contributing predictors of enteral autonomy noted have 
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been percent of daily energy intake tolerated through the enteral route, presence of the 
ileocecal valve, and underlying NEC. 16,55,56 A 2008 retrospective study found that those 
patients weaned from PN by two and on-half years after referral to a multidisciplinary 
intestinal rehabilitation center achieved 95% survival after five years compared to 52% 
for those patients not weaned from PN.9 A 2014 retrospective study found 78%, in total, 
were weaned from PN, and while the primary predictor of PN wean was intestinal length, 
of those with less than 50 cm of intestinal length, 71% weaned from PN, indicating that 
achievement of enteral autonomy is still possible for patients regardless of intestinal 
length.47  Another retrospective cohort study found that over an average of 5.1 years, 
64% of pediatric SBS patients had successfully weaned from PN, and presence of the 
ileocecal valve and age-adjusted bowel length were significant predictors of enteral 
autonomy.16 A multicenter, retrospective cohort analysis of 272 infants found that 43% 
achieved enteral autonomy, and achievement of enteral autonomy was promoted with 
preservation of the ileocecal valve, longer bowel length, and underlying NEC.55 While 
many studies indicate the role of the ileocecal valve in achieving enteral autonomy, 
others have shown that the ileocecal valve is not a contributing factor in reducing PN 
dependence.16,55,56 
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CHAPTER III 
Materials and Methods 
Study Design 
The project is an observational retrospective study with a large cohort of infants 
and children who have SBS/IF.  Study variable data were extracted from an existing 
registry.  The de-identified registry was reviewed to obtain demographic characteristics, 
medical history, modes of nutrition therapy, nutritional intake, and growth starting at the 
time of referral and quarterly or biannually thereafter until achievement of enteral 
autonomy, intestinal transplantation, or death.      
 
Sample Population 
The Intestinal Care and Rehabilitation Center (ICARE) at Children’s Hospital of 
Pittsburgh of the University of Pittsburgh Medical Center (UPMC) is staffed by an 
interdisciplinary team of pediatric specialists including gastroenterologists, pediatric 
surgeons, transplant surgeons, clinical dietitians, a clinical nurse specialist, a social 
worker, and an occupational therapist. Each patient is evaluated with a history and 
physical examination, review of pertinent laboratory data, and nutritional assessment. 
Subsequently, a coordinated treatment plan and goals are constructed, implemented and 
communicated to referring physicians.  Families are recruited and consented for select 
components of their child’s medical information to be included in the ICARE registry at 
the time of a regularly scheduled clinic visit.  Based on ICARE registry data from 2008, 
the mode of nutritional therapy for the vast majority of patients referred to the center is 
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PN with or without enteral supplementation (~85%), followed by oral intake 
alone (~10%) and enteral tube feedings with or without oral intake (~5%).5  Eligibility 
criteria for the current study includes: 1) referral to the ICARE center between 2006 and 
2015, diagnosis with SBS or Intestinal Failure at <12 months of age, 2) weaned from PN 
while receiving medical care by the ICARE center team, 3) receipt of a continuous tube 
feeding with or without oral diet or oral diet alone during weaning, and 4) minimum of 
one year of follow-up data after PN weaning.  Children were excluded from the current 
study if PN was weaned prior to referral, if the child received an intestinal transplant, if a 
tube feeding was received after PN weaning, if tube feedings were provided as bolus 
feedings with an oral diet during weaning, or if PN was not weaned prior to data analysis. 
 
Procedures and Measures 
The study principal investigator (PI) and student PI extracted select data variables 
from the ICARE registry for the purpose of the current study.  Data included the 
following variables: 
 Demographic characteristics (gender, race, gestational age, age at first ICARE 
visit, medical diagnoses) 
 Intestinal characteristics (small bowel length and anatomy, percent of small bowel 
remaining after initial surgery*) 
 Physical assessment by systems at the time of referral (presence of liver disease 
[serum total bilirubin >5] and lung disease) 
 Anthropometric indices (weight, length/height, weight for length/height, and head 
circumference measures, BMI, percentiles, z-scores)** 
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 Mode of nutrition therapy (PN, EN, oral diet) and percent of total daily calories 
from parenteral and enteral sources 
 Transplant status 
 Death 
 Nutritional outcomes (enteral autonomy [>3 months off of PN], transition from 
enteral tube feeding to oral feeding) 
   
*The percent of small bowel remaining after initial surgery was estimated using normal 
values for intestinal length identified by Touloukian.57 
**Weight (kilograms) was measured with a digital medical scale, height (centimeters) 
was determined using a stadiometer.  Infants and toddlers (newborn to 18 months) had 
their weight and length measured using a digital infant scale and recumbent length board.  
Gestation adjusted weight-for-age, length/height-for-age and weight-for-length/height 
percentiles were determined using gender specific WHO/CDC growth charts for infants 
birth-24 months and 2-20 years.58   
 
Data Management and Analysis 
Data were cleaned and examined for missing data, outliers, and meeting the 
assumptions of normality prior to analysis.  Demographic and clinical characteristics, 
modes of nutrition therapy, and linear growth were described using frequency statistics.  
Demographic, anthropometric, and clinical characteristics were compared between 
feeding method using an independent samples t-Test for continuous variables that were 
normally distributed (gestational age, weight z-score at baseline, height z-score at 
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baseline, height z-score at year 1 post-wean, height z-score at year 2 post-wean, 
difference between height z-score from time of weaning and year 1 post-wean, and 
difference between height z-score from time of weaning and year 2 post-wean) or the 
Mann Whitney U test for variables that were skewed (age at referral, total bilirubin, direct 
bilirubin, total small bowel length, percent small bowel remaining, and time to PN wean 
from initial visit).  The Chi-square test was used to determine differences by tube feeding 
status for categorical variables (gender, race, presence of ileocecal valve, and intestinal 
procedures).   
The Kaplan-Meier survival statistic was used to examine the difference in 
survival by mode of nutrition therapy during weaning at two-years post-wean. The z-
score statistic was used to standardize values of relative position on a percentile growth 
curve to obtain an overall assessment of growth in the sample population, which includes 
children of varying age and gender.  The positive or negative trends in growth velocities 
and z-scores between baseline measurements and those taken at subsequent time points 
were assessed over a two-year period after PN weaning using the repeated measures test. 
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CHAPTER IV 
Results 
The electronic medical records of 114 patients initially seen at the ICARE center 
between June 2006 and November 2015 were reviewed. At the time of the review, 38 
patients had not weaned from PN, 24 patients had undergone intestinal transplant, 4 
patients received bolus tube feedings during the weaning process, and 3 patients were lost 
to follow up within the first year after the initial visit. The final sample included 45 
patients with short bowel syndrome or intestinal failure who met the study inclusion 
criteria. Twenty-one of the 45 patients (47%) received a continuous enteral tube feeding 
with an oral diet during the weaning process while 24 patients (53%) were weaned 
directly to an oral diet without tube feeding support. The majority of the participants were 
male (64%), Caucasian (73%), and non-Hispanic (100%). The demographic, 
anthropometric, and clinical characteristics of the sample population at the time of 
referral by mode of nutrition therapy during PN weaning are shown in Tables 1 and 2.  
Several differences between feeding groups were observed.  A higher percentage of 
children in the oral diet vs. TF group were male (79% vs. 48%, respectively; p=0.027).  
Children weaned to an oral diet were younger than those who received a tube feeding (1 
to 2 months vs. 6 months, respectively; p=0.029).   In addition, children weaned to an 
oral diet had a higher serum direct bilirubin level at the time of referral than those who 
received a continuous tube feeding (1.9 mg/dL vs. 0.1 mg/dL, respectively; p=0.045). 
The majority (64%) of the children weaned from PN who were referred to the 
ICARE center between 2006 and 2009 (n=22), received a continuous tube feeding during 
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the weaning process.  Those who were referred between 2010 and 2015 (n=23) were 
primarily weaned directly to oral diet (70%).  Time to complete the weaning process 
from the date of the initial visit did not differ significantly between patients who received 
a continuous enteral tube feeding and those who received only oral diet (p=0.345). The 
median time for patients who received a tube feeding was 14.0 months (Interquartile 
Range [IQR]; 9.5, 36.0) while the median time for patients who did not receive an enteral 
tube feeding was 21.5 months (IQR; 14.5, 41.0).  No patient deaths occurred within the 
first two years after PN weaning; therefore, the probability of survival did not differ 
significantly between patients who received an enteral tube feeding during weaning and 
those who did not.   
Mean height z-score values did not differ between children who did and did not 
receive a continuous enteral tube feeding during the PN weaning process at baseline 
(p=0.608), year one post-wean (p=0.220), or year two post-wean (p=0.126).  Repeated 
measures analysis of linear growth between the time of PN weaning to two-years post-
wean was not significant for either feeding method (TF, p=0.116; oral diet, p=0.436). 
Patients who weaned from PN directly to an oral diet had a smaller decrease in z-score 
from the time of weaning to year one than those who received a continuous enteral tube 
feeding (-0.05 vs. -0.43, respectively; Table 3) and a larger increase in z-score from year 
one to year two after PN wean (+0.22 vs. +0.02, respectively; Table 4).  The mean 
change in height z-score from time of weaning to year one post-wean was not 
significantly different between feeding method groups (p=0.228). The same was true for 
year one post-wean to year two post-wean (p=0.251).  The mean height z-scores for those 
 
 
 
 
37 
who received a continuous enteral tube feeding with an oral diet compared to those who 
consumed an oral diet only over the two-year follow-up period are shown in Figure 1.  
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Table 1: Demographic and Anthropometric Characteristics of the Intestinal Care and 
Rehabilitation Center Sample Population by Feeding Method during Parenteral Nutrition 
Weaning 
Characteristic 
Tube Fed 
n = 21 
Oral Diet 
n = 24 P-Value 
Gender 
n (%) 
     Male 
     Female 
10 (48) 
11 (52) 
19 (79) 
5 (21) 0.027 
Gestational age 
(weeks)* 34.3 ± 4.1 33.5 ± 4.5 0.542 
Age at referral 
(years)** 0.5 (0.2, 2.2) 0.10 (0.00, 0.30) 0.029 
Race 
n (%) 
     Caucasian 
     Black 
     Asian 
     Native American 
     Other 
16 (76) 
4 (19) 
0 (0) 
0 (0) 
1 (5) 
17 (71) 
6 (25) 
1 (4) 
0 (0) 
0 (0)  
Wt z-Score at 
Baseline* -1.29 ± 1.98 -0.69 ± 1.25 0.242 
Ht z-Score at 
Baseline* -1.76 ± 2.75 -1.25 ± 1.85 0.463 
Ht - height, Wt - weight 
*Mean + Standard Deviation 
**Median (Interquartile Range, 25%, 75%) 
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Table 2: Baseline Clinical Characteristics of the Intestinal Care and Rehabilitation Center 
Sample Population by Feeding Method during Parenteral Nutrition Weaning 
 
Characteristic 
Tube Feeding 
(n = 21) 
Oral Diet 
(n = 24) 
 
P-Value 
Serum Total bilirubin 
(mg/dL)* 
2.9 (0.4, 7.3) 3.8 (2.2, 5.0) 0.393 
Serum Direct bilirubin 
(mg/dL)*+ 
0.1 (0.1, 2.6) 1.9 (0.3, 3.3) 0.045 
Small bowel length 
(cm)*++ 
45.0 (28.0, 
85.0) 
41.0 (17.0, 64.0) 0.248 
Percent small bowel 
remaining*+++ 
23.5 (12.4, 
93.8) 
17.5 (8.0, 23.0) 0.159 
Presence of ileocecal 
valve++++ 
n (%) 
 
8 (38) 
 
10 (42) 
 
0.664 
Time to PN Wean from 
Initial Visit (months) 
 
14.0 (9.5, 
36.0) 
 
21.5 (14.3, 41.0) 
 
0.345 
Intestinal Procedures 
n (%) 
     Bianchi Bowel Split 
     STEP Procedure 
 
 
2 (10) 
5 (24) 
 
 
1 (4) 
4 (17) 
 
 
0.592 
0.713 
cm – centimeters, PN – parenteral nutrition, STEP – serial transverse enteroplasty 
*Median (Interquartile Range; 25%, 75%) 
+n = 13 (tube feeding), 22 (oral diet) 
++n = 15 (tube feeding), 23 (oral diet) 
+++n = 18 (tube feeding), 23 (oral diet) 
++++n = 19 (tube feeding), 24 (oral diet) 
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Table 3: Change in Height z-Score from Parenteral Nutrition Wean to 1 Year after Wean 
 n 
Height z-
Score*   
Wean 
1 Year  
Post-Wean 
Change in 
Height z-
Score P-Value 
Tube 
Feeding 
21 -1.85 ± 1.99 -2.28 ± 1.78 -0.43 0.108 
Oral Diet 22 -1.68 ± 1.37 -1.73 ± 1.08 -0.05  0.804 
 
*Mean + Standard Deviation 
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Table 4: Change in Height z-Score from 1 Year to 2 Years after Parenteral Nutrition 
Wean 
 n 
Height z-
Score*   
1 Year  
Post-Wean 
2 Year  
Post-Wean 
Change in 
Height z-
Score P-Value 
Tube 
Feeding 
17 -2.10 ± 1.89 -2.08 ± 1.76 +0.02 0.916 
Oral Diet 20 -1.63 ± 1.08 -1.41 ± 1.07 +0.22 0.065 
 
*Mean + Standard Deviation 
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Figure 1: Mean Height z-Scores at the Time of Parenteral Nutrition Wean and One- and 
Two-Years Post-Wean by Feeding Method during Parenteral Nutrition Weaning  
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CHAPTER V 
Discussion 
In 2010, the ICARE Center adopted a change in nutrition management strategy 
for patients with SBS and IF that involved weaning from PN directly to an oral diet 
without the use of supplementary tube feedings. This change in treatment provided an 
opportunity to evaluate outcomes in patients who received a continuous enteral tube 
feeding vs. those that received bolus oral feedings. This observational retrospective 
cohort study examined the effects of weaning from PN using a supplemental continuous 
enteral tube feeding vs. progressing directly to an oral diet in 45 patients with SBS or IF.   
The feeding groups were homogenous in their characteristics except for three 
variables: gender, age, and serum direct bilirubin level.  The difference in gender 
distribution between the two feeding method groups are not likely to have influenced the 
study outcomes.  Children in the oral diet group were significantly younger at the time of 
referral although there was no difference in mean gestational age.  A primary 
management goal for children with SBS is to reduce the concentration of nutrients 
provided by PN while enteral nutrient intake is subsequently increased.  The medical 
team would have been more likely to prescribe a continuous tube feeding with feeding 
therapy for a child with oral aversion vs. an oral diet alone in order to facilitate weaning 
from PN.  Moreover, during the first 3 years of life, critical periods for feeding skill 
development occur.59  Feeding and swallowing behaviors transition from reflexive to 
learned  around 4-6 months of age.60,61  Therefore, children whose oral intake is delayed 
often have diminished willingness to try unfamiliar foods and difficulty developing oral-
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motor skills necessary for eating.62,63  Children in the oral diet group were significantly 
younger; therefore, they were likely exposed to oral opportunities to eat sooner and 
started to develop necessary oral-motor skills during a critical development period.  The 
ICARE registry does not include an assessment of oral aversion at the time of referral.  
Elevated serum direct bilirubin levels (normal range 0.0 to 0.5 mg/dL) in the oral diet 
group indicate that these patients may have had a greater degree of liver dysfunction at 
the time of referral.  Prolonged cholestasis (>3 months) has been associated with an 
increased risk of mortality;64 however, the mean serum direct bilirubin level in either 
group did not meet the definition of cholestasis (>2 mg/dL) reported by the Pediatric 
Intestinal Failure Consortium.55   
The current study focused on evaluating the impact of feeding method on three 
outcomes: time to complete weaning from PN, survival, and linear growth.  In our 
sample, time to PN wean did not significantly differ between the group that received 
continuous enteral tube feedings and those who received an oral diet alone. Therefore, we 
fail to reject our null hypothesis that the time to achieve enteral autonomy would not 
differ by PN weaning approach. No previous studies have examined the difference in 
time to wean between patients by mode of feeding during PN weaning. The probability of 
survival did not significantly differ between feeding method groups; therefore, we fail to 
reject the null hypothesis that survival time will not differ by PN weaning approach. 
While one death occurred in a patient who received a continuous enteral tube feeding 
during weaning, this death was associated with liver tumor reoccurrence and not related 
to intestinal failure or mechanical issues from tube feeding. Previous studies have shown 
that enteral tolerance is significantly related to mortality, and enteral autonomy offers the 
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best chance of survival.14,65  No other studies have examined survival between patients 
who weaned with an enteral tube feeding and those that weaned without enteral tube 
feeding.  
Linear growth velocity did not significantly decline or increase within two years 
post PN wean.  In addition, mean values of height z-score at the time of weaning, one 
year after weaning, and two years after weaning were not significantly different between 
the feeding method groups.  Therefore, we fail to reject the null hypothesis that growth 
will not differ by PN weaning approach.  Of clinical significance, both groups 
experienced a decrease in height z-score from the time of wean to one year after wean. 
The patients who received a continuous tube feeding experienced a larger mean decrease 
in z-score than the group that weaned directly to oral diet. From year one to year two 
after wean, both groups experienced a rebound in positive linear growth. The patients 
who weaned directly to oral diet had a larger increase than those who received a 
continuous oral tube feeding. Some degree of intestinal malabsorption may be an 
explanation for this observed decrease in linear growth velocity during the first year 
following wean from PN.  Intestinal adaptation may take one to three years in children, 
which may explain the late increase in growth velocity after PN wean.64   
There are some limitations to our study. Caloric intake of neither the tube feeding 
nor the oral diet was recorded.  One possible explanation for the less favorable response 
by the tube-feeding group is that energy intake was insufficient to meet nutritional 
requirements for growth.  Prior to referral to the ICARE center, some patients may have 
had a period of care at an outside facility. Some patients may also have already received 
enteral or parenteral nutrition prior to referral. The care received prior to first visit at the 
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ICARE center could impact clinical and anthropometric characteristics and time to PN 
wean.  The addition of a bolus tube feeding group would help further explain the effects 
of feeding methods during weaning.  While a continuous tube feeding may result in 
improved intestinal absorption due to the increased presence of nutrients, intermittent 
feedings are advantageous for intestinal adaptation because they produce cyclical changes 
in gastrointestinal hormones that more closely mimic normal gastrointestinal 
physiology.15,21  This may result in more timely and successful weaning to oral diet.15  
Future studies including children who have received bolus tube feedings could expand 
upon the findings of this study by evaluating the difference in outcomes by continuous or 
intermittent feeding regardless of route. While the current study included a moderately-
sized sample of patients with SBS or IF, the development of a multicenter registry would 
provide a larger sample size to assess the effect of feeding method or type of food or 
formula on nutrition related outcomes. Finally, patients were included in the tube feeding 
group if they received a continuous tube feeding at any point during the PN weaning 
process; therefore, the contribution of the tube feeding to nutritional intake varied 
between patients. 
In conclusion, no association between weaning strategy and outcomes in children 
with IF was observed.  Linear growth velocity declined during the first year after PN 
weaning but rebounded in year two.  Children weaned directly to an oral diet exhibited a 
more favorable growth pattern after weaning than those supported by continuous tube 
feeding.  Growth pattern changes between groups highlight the need for future studies 
that include an energy intake variable to assess the impact of nutritional intake on linear 
growth.  Future studies should define the continuous tube feeding variable and include a 
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bolus tube feeding group to investigate the role of intermittent versus continuous feeding 
on time to PN weaning.  Development of a multicenter prospective study to assess 
nutritional interventions in children with intestinal failure would provide further basis for 
strategies to shorten time on PN, reduce morbidity and mortality associated with PN use, 
and improve growth outcomes.
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Appendix A 
Normal Functions of the Small Intestine 
Duodenum Jejunum Ileum Ileocecal Valve 
Iron absorption 
Secretion 
 Cholecystokinin 
 Secretin 
Nutrient absorption 
 Glucose 
 Amino 
Acids 
 Fat 
 Calcium 
 Magnesium 
 Folate 
 Iron 
 Thiamine 
 Vitamin C 
Reabsorption 
 Fluid and 
electrolytes 
Absorption 
 Bile acids 
 Conjugated 
bile salts 
 Vitamin B12 
 Vitamins A, D, 
E, K 
 Phosphorus 
 Zinc 
Secretion 
 Enteroglucagon 
Slows intestinal 
transit time 
Prevents bacterial 
reflux into 
small intestine 
 
*Adapted from Jakubik et al. (2000)19 
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Physiologic Response to Intestinal Resection 
Loss of Jejunum Loss of Ileum Loss of Ileocecal Valve 
Some nutrient malabsorption 
(ileum can adapt much of 
the nutrient absorption 
capacity of the jejunum) 
Malabsorption of 
 Calcium 
 Magnesium 
 Folate 
 Iron 
 Thiamine 
 Vitamin C 
Steatorrhea 
Cholestasis 
Malabsorption of 
 Bile acids 
 Conjugated bile acids  
 Vitamin B12 
 Fat 
 Vitamins A, D, E, K 
 Phosphorus 
 Zinc 
Steatorrhea 
Fluid and electrolyte 
abnormalities 
Decreased intestinal transit 
time (increased 
malabsorption) 
Increased fluid and 
electrolyte losses 
Reflux of bacterial content 
into small intestine causes 
bacterial overgrowth 
leading to:  
Increased malabsorption 
(especially fat 
malabsorption) 
 
*Adapted from Jakubik et al. (2000)19 
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Nutrition-Focused Physical Examination Findings 
Area Normal Findings Abnormal Findings Related Nutrition 
Deficiencies 
Hair Smooth and 
symmetrically 
distributed 
Poor quality Zinc, essential fatty acid, 
biotin, protein-calorie 
Eyes Bright, shiny, 
clear, pink moist 
membranes 
Dull, dry membranes 
with Bitot spots 
Vitamin A 
Lips/Mouth Pink, free of 
lesions 
Dry, swollen 
 
Dry mucous membranes 
Dry mouth 
Vitamin B6, folate, riboflavin, 
niacin, vitamin B12, iron 
Dehydration 
Zinc 
Tongue Moist pink with 
slightly rough 
texture 
Magenta and edematous 
 
Enlarged in congenital 
anomalies 
Candidiasis lesions or 
thrush 
Riboflavin, niacin, folate, B6, 
B12, iron 
May lead to feeding issues 
 
Vitamin C, iron 
Gums Pink without 
lesions 
Bleeding and inflamed Vitamin C 
Teeth Normal eruption 
begins at 4-12 
months 
Delayed eruption 
Dental caries 
Severe malnutrition 
Vitamin D 
Skin Uniform color 
without rashes, 
tears, or flaking 
Pallor Iron, folate, vitamin B12 
Nails Symmetrical and 
smooth 
Transverse lines 
Flaky 
Poorly blanched 
Protein 
Magnesium 
Vitamins A and C 
 
*Adapted from Corkins et al. 201735  
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Appendix B 
Primary Indicators of Malnutrition When Single Data Point Available 
Indicator Mild Malnutrition Moderate 
Malnutrition 
Severe Malnutrition 
Weight-for-length z 
score 
-1 to -1.9 z score -2 to -2.9 z score Below -3 z score 
BMI-for-age z score -1 to -1.9 z score -2 to -2.9 z score Below -3 z score 
Length/height-for-age 
z score 
No data No data Below -3 z score 
Mid-upper arm 
circumference 
-1 to -1.9 z score -2 to -2.9 z score Below -3 z score 
 
*Adapted from Corkins et al. 201735 
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Primary Indicators of Malnutrition When 2 or More Data Points Available 
Indicator Mild Malnutrition Moderate 
Malnutrition 
Severe Malnutrition 
Weight gain velocity 
(<2 years of age) 
Less than 75% of the 
norm for expected 
weight gain 
Less than 50% of the 
norm for expected 
weight gain 
Less than 25% of 
the norm for 
expected weight 
gain 
Weight loss (2-20 
years of age) 
5% usual body 
weight 
7.5% usual body 
weight 
10% usual body 
weight 
Deceleration in 
weight-for-
length/height (BMI) 
z score 
Decline of 1 z score Decline of 2 z score Decline of 3 z score 
Inadequate nutrient 
intake 
51%-75% estimated 
energy/protein need 
26%-50% estimated 
energy/protein need 
<25% estimated 
energy/protein need 
 
*Adapted from Corkins et al. 201735 
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Appendix C 
Calculating Energy Needs for Pediatric Critically Ill Patients42 
Name of Equation or Formula and 
Source 
Formula 
Energy Requirements 
Schofield66 Males 
0 to 3 y: (0.17 x weight [kg]) + (15.17 x height 
[cm]) – 617.6 
3 to 10 y: (19.6 x weight [kg]) + (1.303 x height 
[cm]) + 414.9 
10 to 18 y: (16.25 x weight [kg]) + (1.372 x 
height [cm]) + 515.5 
Females 
0 to 3 y: (16.25 x weight [kg]) + (10.232 x height 
[cm]) – 413.5 
3 to 10 y: (16.97 x weight [kg]) + (1.618 x height 
[cm]) + 371.2 
10 to 18 y: (8.365 x weight [kg]) + (4.65 x height 
[cm]) + 200 
Food and Agriculture 
Organization/World Health 
Organization66 
Males 
0 to 3 y: (60.7 x weight [kg]) – 54 
3 to 10 y: (22.7 x weight [kg]} + 495 
10 to 18 y: (17.5 x weight [kg]) + 651 
Females 
0 to 3 y: (61 x weight [kg]) – 51 
3 to 10 y: (22.5 x weight [kg]} + 499 
10 to 18 y: (12.2 x weight [kg]) + 746 
Protein Requirements 
ASPEN Clinical Guidelines Nutrition 
Support for the Critically Ill Child67 
i. 0 to 2 y: 2 to 3 
g/kg/day 
ii. 2 to 13 y: 1.5 to 2 
g/kg/day 
iii. Adolescents: 1.5 
g/kg/day 
 
cm – centimeters, g – grams, kg - kilograms  
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Enteral and Parenteral Requirements of the Very Low-Birthweight Premature 
Infant 
Nutrient Parenteral (unit/kg/day) Enteral (unit/kg/day) 
Energy (kcal/kg) 110-120 110-135 
Protein (g/kg) 1.5-4.0 3.5-4.0 
Carbohydrate (g/kg) 13-18 11.6-13.2 
Fat (g/kg) 3-4 4.8-6.6 
Na (mmol/kg) 3.5-5.0 3.0-5.0 
K (mmol/kg) 2.5-5.0 1.7-3.4 
Cl (mmol/kg) 2.0-3.0 3.0-5.0 
Ca (mmol/kg) 1.5-2.0 3.0-3.5 
 
*Table adapted from Rossouw et al. 2016 
Ca – calcium, Cl – chlorine, g – gram, K – potassium, kcal – kilocalorie, kg – kilogram, 
mmol – millimole, Na - sodium 
